| Gerard Jules Galarneau, MD | |
|
707 E Main St, Middletown, NY 10940-2650 | |
| (845) 333-7575 | |
| (845) 333-7202 |
| Full Name | Gerard Jules Galarneau |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 29 Years |
| Location | 707 E Main St, Middletown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235222936 | NPI | - | NPPES |
| 02053170 | Medicaid | NY | |
| 210862-9W | Other | WORKERS COMPENSATION NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 210862 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Garnet Health Medical Center | Middletown, NY | Hospital |
| Garnet Health Medical Center Catskills | Harris, NY | Hospital |
| Grover Hermann Division | Callicoon, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Garnet Health Doctors Pc | 8628293545 | 156 |
News Archive
"The pharmaceutical marketing industry is, to borrow from a friend, in a perfect storm," says Cheryl Lawrence McDaniel, Owner, President & Chief Executive Officer, Direct Success, Inc.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is the result of a report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 11 January 2011.
Pro-Pharmaceuticals, Inc. today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company's core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer.
› Verified 4 days ago
| Entity Name | Garnet Health Doctors Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093138851 PECOS PAC ID: 8628293545 Enrollment ID: O20140710000189 |
News Archive
"The pharmaceutical marketing industry is, to borrow from a friend, in a perfect storm," says Cheryl Lawrence McDaniel, Owner, President & Chief Executive Officer, Direct Success, Inc.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is the result of a report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 11 January 2011.
Pro-Pharmaceuticals, Inc. today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company's core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gerard Jules Galarneau, MD 707 E Main St, Middletown, NY 10940-2650 Ph: (845) 333-7575 | Gerard Jules Galarneau, MD 707 E Main St, Middletown, NY 10940-2650 Ph: (845) 333-7575 |
News Archive
"The pharmaceutical marketing industry is, to borrow from a friend, in a perfect storm," says Cheryl Lawrence McDaniel, Owner, President & Chief Executive Officer, Direct Success, Inc.
Nature Technology Corporation "NTC" and Aldevron today announced a joint effort to manufacture the world's first plasmid DNA-based genetic cosmetic for Gene Facelift.
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is the result of a report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 11 January 2011.
Pro-Pharmaceuticals, Inc. today announced that it has changed its name to Galectin Therapeutics Inc. to more accurately reflect the Company's core expertise in galectin science and its leading platform for the creation of galectin inhibitors to treat serious diseases including fibrosis and cancer.
› Verified 4 days ago
Felix S Davelman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 95 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Steven J Rowe, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 95 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Michael Ethan Hoffman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 Fax: 845-333-7202 | |
Dr. Rohit A Patel, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 25, Myrtle Avenue, Middletown, NY 10940 Phone: 845-343-4141 Fax: 845-343-1535 | |
Dr. Christopher S. Han, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 95 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999 Fax: 845-703-6297 | |
Dr. Samuel Abourbih, MD,CM Urology Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575 Fax: 845-333-7202 |